Johnson Investment Counsel’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,500
Closed -$1.14M 829
2025
Q3
$1.14M Hold
1,500
0.01% 398
2025
Q2
$1.17M Sell
1,500
-1,500
-50% -$1.17M 0.01% 389
2025
Q1
$2.48M Buy
+3,000
New +$2.5M 0.02% 247

Other funds holding LLY

Johnson Investment Counsel's LLY Position: Q2 2026 in Review

Johnson Investment Counsel reduced its Eli Lilly (LLY) stake by 5.5% in Q2 2026, selling an estimated $1.97M and leaving 33,088 shares worth $39.7M. The position accounts for 0.29% of the portfolio, ranked #81.

Johnson Investment Counsel first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. 1,653 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Johnson Investment Counsel held 33,088 shares of Eli Lilly worth $39.7M as of Q2 2026.
  • Johnson Investment Counsel sold 1,927 Eli Lilly shares in Q2 2026, an estimated $1.97M.
  • Eli Lilly made up 0.29% of Johnson Investment Counsel's portfolio in Q2 2026, its #81 holding.
  • Johnson Investment Counsel first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
  • 1,653 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Johnson Investment Counsel's 13F filing for Q2 2026, filed 23 Jul 2026.